During the three months ended March 31, 2026, the Company incurred restructuring costs of $2.8 million as part of the broader efforts to optimize the Company’s cost structure. The restructuring costs primarily consisted of severance payments, employee benefits, exit charges associated with the closure of facilities and related costs. The Company expects to substantially complete these actions in 2026, subject to local law and consultation requirements in certain countries. The Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur as a result of or in connection with the implementation of these actions.

The following table summarizes the Company’s restructuring costs that were recorded as an operating expense in the accompanying Condensed Consolidated Statements of Operations during the three months ended March 31, 2026 and 2025 (in thousands):


	Three Months Ended March 31,
		2026		2025
Cost of revenues		$	528	$	1,535
Research and development		557		1,694
Sales and marketing		642		2,988
General and administrative		1,116		873
Total restructuring costs		$	2,843	$	7,090

The following table summarizes the Company’s restructuring liability that is included in accrued liabilities in the accompanying Condensed Consolidated Balance Sheets (in thousands):


Balance as of December 31, 2025	$	2,834
Restructuring costs	2,843
Cash payments	(4,066)
Non-cash and other adjustments	(752)
Balance as of March 31, 2026	$	859